{"id":"azedra","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT00659984","NCT00458952","NCT01370330","NCT00874614","NCT04614766","NCT02961491"],"aliases":["iobenguane I-131"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"","brandName":"Azedra","companyId":"david-bushnell","ecosystem":[],"mechanism":{"target":"Sodium-dependent noradrenaline transporter","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"David Bushnell","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"Azedra","indications":{"approved":[{"name":"Paraganglioma","diseaseId":"paraganglioma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pheochromocytoma","diseaseId":"pheochromocytoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT00659984","phase":"Phase 2","title":"A Phase 2a Study of Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma","status":"COMPLETED","sponsor":"Molecular Insight Pharmaceuticals, Inc.","isPivotal":false,"enrollment":15,"indication":"Neuroblastoma","completionDate":"2010-11"},{"nctId":"NCT00458952","phase":"Phase 1","title":"A Phase I Study Evaluating the Maximum Tolerated Dose, Dosimetry, Safety, and Efficacy of Ultratrace Iobenguane I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma","status":"COMPLETED","sponsor":"Molecular Insight Pharmaceuticals, Inc.","isPivotal":false,"enrollment":24,"indication":"Pheochromocytoma, Paraganglioma","completionDate":"2011-06"},{"nctId":"NCT01370330","phase":"N/A","title":"131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol","status":"AVAILABLE","sponsor":"Kieuhoa Vo","isPivotal":false,"enrollment":0,"indication":"Neuroblastoma","completionDate":""},{"nctId":"NCT00874614","phase":"Phase 2","title":"A Phase II Study Evaluating the Efficacy and Safety of Ultratrace Iobenguane I 131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma","status":"UNKNOWN","sponsor":"Molecular Insight Pharmaceuticals, Inc.","isPivotal":false,"enrollment":74,"indication":"Pheochromocytoma, Paraganglioma","completionDate":"2021-02"},{"nctId":"NCT04614766","phase":"Phase 1","title":"A Phase 1/2 Trial Using AZEDRA and LUTATHERA in a Dosimetrically-determined Optimal Combination for Therapy of Selected Patients With Midgut Neuroendocrine Tumors","status":"WITHDRAWN","sponsor":"David Bushnell","isPivotal":false,"enrollment":0,"indication":"Gastro-enteropancreatic Neuroendocrine Tumor, Neuroendocrine Tumors","completionDate":"2024-04-23"},{"nctId":"NCT02961491","phase":"N/A","title":"Expanded Access Program of AZEDRA (Ultratrace Iobenguane I131) in Subjects With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma: A Sub-study of Protocol MIP-IB12B","status":"APPROVED_FOR_MARKETING","sponsor":"Molecular Insight Pharmaceuticals, Inc.","isPivotal":false,"enrollment":0,"indication":"Pheochromocytoma, Paraganglioma","completionDate":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Nephrology"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":3,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}